Changes to the Supply Agreement with Cann Group

FOR PUBLIC RELEASE
NZX Limited
Wellington

4
th
December 2023

Changes to the Supply Agreement with Cann Group

Rua Bioscience today announces that Cann Group has given 12 months’ notice to terminate
its existing supply contract with Rua Bioscience.

In response to Cann’s decision, Rua Bioscience has engaged legal advice to consider options.

There have been recent quality issues with Cann’s export products, which had already
prompted Rua Bioscience to proactively explore alternative supply partnerships.

In the last 12 months, Rua has placed emphasis on securing multiple additional supply
pathways with particular emphasis on cultivating our unique genetics in Europe and
Australia. We now have more surety that we can consistently supply patients in our key
markets of Germany, Australia and New Zealand.

“While we appreciate the history we have had with Cann, we are committed to ensuring the
continuity of our operations and maintaining the highest standards in product quality” said
Paul Naske, CEO at Rua Bioscience. “

The new supply partnerships will improve supply chain effectiveness and contribute to the
overall growth and success of the company.



MATERIAL ANNOUNCEMENT